Last reviewed · How we verify
NCT06812091
Human Microbiome Research and Development for Overcoming Pediatric Diseases
trial in Human Microbiome in 500 participants. Currently enrolling.
1 January 2026
Quick facts
| Lead sponsor | Hanyang University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 January 2022 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 January 2030 |
| Sites | 1 location across South Korea |
Conditions studied
- Human Microbiome — all drugs for Human Microbiome →
- Pediatrics — all drugs for Pediatrics →
- Disease — all drugs for Disease →
- Growth & Development — all drugs for Growth & Development →
Sponsor
Hanyang University
Who can join
Eligibility, any sex, with Human Microbiome or Pediatrics. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prediction and treatment of pediatric diseases and long-term outcomes through microbiome and multi-omics analysis by life cycle: We aim to demonstrate that a wide range of diseases are associated with gut microbiome dysbiosis and to investigate the subsequent recovery (restoration) or further deterioration of the gut microbiome over time. This study seeks to offer a novel perspective on changes in the gut microbiome, particularly in the context of the gut-lung and gut-brain axes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06812091
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hanyang University trials
Trials by the same sponsor.
- NCT06230302 — Efficacy and Safety of Kefir Whey Postbiotics · NA · unknown
- NCT05579158 — Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Ran · NA · completed
- NCT04449224 — Comparative Effectiveness of Targeted Therapy in RA Patients · unknown
- NCT03983408 — Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease · NA · unknown
- NCT03438903 — Comparison of Repeatability Between SS and SD-OCT for Measuring Retinal Thickness in Various Retinal Diseases · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06812091 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hanyang University
- Last refreshed: 6 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06812091.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing